Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
基本信息
- 批准号:8792874
- 负责人:
- 金额:$ 33.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-04 至 2016-01-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAcuteAddressAffectAmericanApoptoticAttenuatedBehavioralBlood VesselsBrainCell CountCell ProliferationCellsCognitive deficitsCortical ContusionsDefectDevelopmentEnvironmentEph Family ReceptorsEphA4 ReceptorEphB3 ReceptorEphrinsFamily memberFoundationsGanciclovirGene TargetingGrantHealthImmigrationIndividualInjuryKnock-outLaboratoriesLeadLearningMediator of activation proteinMemory impairmentModelingMusMutant Strains MiceNatureOperative Surgical ProceduresOutcomeParalysedPatientsPhase I Clinical TrialsPlayPopulationPostdoctoral FellowProcessRecoveryRecovery of FunctionRoleSensorySignal TransductionSiteSolidSpecificityStem cellsStreamTechnologyTherapeuticTimeTissuesTransgenic MiceTransgenic OrganismsTransplantationTraumatic Brain InjuryTraumatic Brain Injury recoveryTraumatic CNS injuryTumor AngiogenesisUnited StatesVascular remodelingViraladult neurogenesiscell injurycontrolled cortical impactdesigndisabilityexperiencefunctional improvementgain of functionimprovedinjuredloss of functionmigrationmotor disordermouse modelnestin proteinneuroblastneurogenesisneuromechanismneurotransmissionnovel strategiesnovel therapeuticsreceptorrelating to nervous systemrepairedstemsubventricular zone
项目摘要
DESCRIPTION (provided by applicant): Seven million Americans are presently incapacitated as a result of traumatic brain injury (TBI) with 500,000 new patients admitted each year. TBI is a devastating disability that leads to sensory and motor dysfunction, learning and memory impairment, and cognitive deficits. These defects result from, in part, tissue destruction and focal cell losses. Cell replacement strategies have been one approach to restoring brain function, and an alternative to cellular transplantation is stimulation of endogenous neurogenesis. We hypothesize that enhancement of neural stem/progenitor cell (NSPC) numbers through improved proliferation and survival will lead to tissue sparing and behavioral recovery. In acute TBI, this is likely through a mechanism where NSPCs/neuroblasts provide a trophic environment for tissue sparing. We hypothesize that ephrinB3 and its receptors, EphB3 and EphA4, provide a regulatory signal to subventricular zone (SVZ)-derived NSPCs, which limit proliferation, survival, and neuroblast migration to the site of injury. Aim 1 of this grant will examine the role of ephrinB3 and its receptors on NSPC proliferation, survival, and neuroblast migration following cortical contusion impact (CCI) injury using transgenic mouse models and viral over-expression approaches. Aim 2 will examine the specificity of SVZ-derived cells in recovery following CCI injury, and determine whether inhibiting p53 in NSPCs leads to enhance neurogenesis and functional recovery. Aim 3 will examine whether Ephs regulate neuroblast migration through cell autonomous signaling and/or through vascular remodeling. Together, we believe our analysis will clearly address the protective role of the SVZ after TBI, and whether ephrinB3 and its receptors are critical regulators of neurogenesis and TBI recovery. Furthermore, we anticipate our findings will lead to therapeutic strategies to treat TBI patients.
描述(申请人提供):目前有700万美国人因创伤性脑损伤(TBI)而丧失工作能力,每年有500,000名新患者入院。脑外伤是一种毁灭性的残疾,会导致感觉和运动功能障碍、学习和记忆障碍以及认知障碍。这些缺陷的部分原因是组织破坏和局灶性细胞丢失。细胞替代策略一直是恢复大脑功能的一种方法,而细胞移植的另一种选择是刺激内源性神经发生。我们假设,通过改善增殖和存活来增加神经干细胞/祖细胞(NSPC)的数量将导致组织保留和行为恢复。在急性脑损伤中,这可能是通过NSPC/神经母细胞为组织保留提供营养环境的机制来实现的。我们假设ewitinB3及其受体EphB3和EphA4向脑室下区(SVZ)来源的NSPC提供调节信号,限制NSPC的增殖、存活和神经母细胞向损伤部位的迁移。这项拨款的目的1将通过转基因小鼠模型和病毒过度表达方法,研究ewitinB3及其受体在皮质挫伤(CCI)损伤后NSPC增殖、存活和神经母细胞迁移中的作用。目的2检测SVZ来源的细胞在CCI损伤后恢复过程中的特异性,并确定抑制NSPC中的P53是否能促进神经发生和功能恢复。目的3将研究Ephs是否通过细胞自主信号和/或血管重塑来调节神经母细胞的迁移。总之,我们相信,我们的分析将清楚地解决脑损伤后SVZ的保护作用,以及ewitinB3及其受体是否是神经发生和脑损伤恢复的关键调节因子。此外,我们预计我们的发现将导致治疗脑损伤患者的治疗策略。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Traumatic brain injury-induced hippocampal neurogenesis requires activation of early nestin-expressing progenitors.
创伤性脑损伤引起的海马神经发生需要激活早期表达巢穴的祖细胞。
- DOI:10.1523/jneurosci.4629-08.2008
- 发表时间:2008-11-26
- 期刊:
- 影响因子:0
- 作者:Yu TS;Zhang G;Liebl DJ;Kernie SG
- 通讯作者:Kernie SG
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Jon Liebl其他文献
Daniel Jon Liebl的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Jon Liebl', 18)}}的其他基金
Stabilizing the tripartite synaptic complex following TBI
TBI 后稳定三方突触复合体
- 批准号:
10844877 - 财政年份:2023
- 资助金额:
$ 33.47万 - 项目类别:
Stabilizing the tripartite synaptic complex following TBI
TBI 后稳定三方突触复合体
- 批准号:
10056316 - 财政年份:2017
- 资助金额:
$ 33.47万 - 项目类别:
Stabilizing the Tripartite Synaptic Complex Following TBI
TBI 后稳定三方突触复合体
- 批准号:
10581933 - 财政年份:2017
- 资助金额:
$ 33.47万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
7106557 - 财政年份:2005
- 资助金额:
$ 33.47万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
8105912 - 财政年份:2005
- 资助金额:
$ 33.47万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
6966621 - 财政年份:2005
- 资助金额:
$ 33.47万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
8415579 - 财政年份:2005
- 资助金额:
$ 33.47万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
8215756 - 财政年份:2005
- 资助金额:
$ 33.47万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
7597062 - 财政年份:2005
- 资助金额:
$ 33.47万 - 项目类别:
Ephrins regulate stem cell proliferation following TBI
Ephrins 调节 TBI 后干细胞增殖
- 批准号:
8606255 - 财政年份:2005
- 资助金额:
$ 33.47万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 33.47万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 33.47万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 33.47万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 33.47万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 33.47万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 33.47万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 33.47万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 33.47万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 33.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 33.47万 - 项目类别:
Operating Grants